alpha-aminopyridine has been researched along with Salivary Gland Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, P; Liu, X; Wu, H; Zhang, F | 1 |
1 other study(ies) available for alpha-aminopyridine and Salivary Gland Neoplasms
Article | Year |
---|---|
JQ1 and PI3K inhibition synergistically reduce salivary adenoid cystic carcinoma malignancy by targeting the c-Myc and EGFR signaling pathways.
Topics: Aminopyridines; Apoptosis; Azepines; Carcinoma, Adenoid Cystic; Cell Cycle Proteins; Cell Proliferation; Cell Survival; Drug Synergism; Drug Therapy, Combination; ErbB Receptors; Gene Expression; Humans; Molecular Targeted Therapy; Morpholines; Nuclear Proteins; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-myc; Salivary Gland Neoplasms; Signal Transduction; Transcription Factors; Triazoles; Tumor Cells, Cultured | 2019 |